13 Breast Cancer and Breast Cancer Awareness Month.mp3: Audio automatically transcribed by Sonix
13 Breast Cancer and Breast Cancer Awareness Month.mp3: this mp3 audio file was automatically transcribed by Sonix with the best speech-to-text algorithms. This transcript may contain errors.
Speaker1:
Welcome to the Cancer Secrets podcast. Changing the Cancer Paradigm. Hosted by Dr. Jonathan Steagall, a medical doctor and cancer specialist practicing in Atlanta, Georgia, deeply affected by his grandmother's death from stomach cancer, as well as patients he cared for in medical training, he realized there has to be a better way to treat cancer. Dr. Stegall has a unique and innovative approach to treating cancer called integrative oncology, combining modern medicine with alternative therapies personalized to each patient. This podcast is designed to educate, support and give you a positive voice you can trust. We invite you to join us on this journey as we seek to change the cancer paradigm.
Speaker2:
Hi. This is Dr. Stegall. I'm so glad you're enjoying the Cancer Secrets podcast. Do you have a question you would like answered in a future episode? If so, please go to Cancer Secrets dot com and click on podcast at the top of the page. Look for the tab on the right side of the page that says Send voice mail. You can record your question straight from your smartphone or computer with your question. Be sure to tell us your first name, where you're from, and why you listen to the show. I will choose from the best questions and answer them on the air. I look forward to hearing from you soon. Hello and welcome back to the Cancer Secrets podcast. I'm your host, Doctor Jonathan Stegall. This is episode number 13. In today's episode, we'll kick off season two and we're going to discuss breast cancer in detail. As many of you know, October is Breast Cancer Awareness Month, and now is a perfect time to take a deep dive into breast cancer. Today, we're going to talk about what breast cancer is. Guidelines for screening, diagnosis and treatment moving forward. And of course, we'll be focusing on an integrative approach as we go through each of these steps. If you're new to this show, please go back and listen to season one. You can go to Cancer Secrets Forward Slash Podcast and listen to all 12 of Season one episodes for free. And as always, I invite you to grab a family member or friend and listen in together.
Speaker2:
Today's show is going to be a great one. Breast cancer has truly become an epidemic. Currently, it's most common cancer in women, excluding skin cancers and the third leading cause of death in cancer in women. And although we typically think of it as a female related disease, and mostly it is men can get breast cancer as well. In today's episode, however, we'll be focusing on breast cancer in women. I consider breast cancer the most personal type of cancer. A woman's breasts are something that she typically will associate with femininity and womanhood. And the idea that the breasts are affected by cancer is extremely personal. I believe more so than most other types of cancer. It's also personal because we all know a woman who's been affected by breast cancer. Mothers, grandmothers, aunts, sisters, daughters, friends. We've all been affected by breast cancer in one way or another. Now, there's a lot of confusion regarding breast cancer, and it deals with the whole idea of nature versus nurture. In other words, genetics versus environment. Now, there's been a lot of talk publicly in the media about genetically inherited breast cancers. This deals with the BRCA one and BRCA two genes. Now, women who do have the BRCA one and or BRCA two genes do have a significantly increased risk of developing breast cancer. And Angelina Jolie is perhaps the most recent example of a woman who was tested for these genes, was found to be positive and decided to prophylactically have a mastectomy and hysterectomy to reduce your risk of developing breast cancer and also female gynaecological cancer, because both are related to the BRCA one and two.
Speaker2:
However, genetically based breast cancer is not nearly as common as we would think. It's actually about 5% of all breast cancers are genetically inherited in terms of the BRCA one and two. So most women are not going to have breast cancer because they inherited BRCA one and two. So that leaves us farther on the end of the nurture side of the nature versus nurture debate. And the nurture side deals with our environment. So as with most cancers, over 90% of them, we're talking about environmental exposures over the years and decades which wear down cells and cause them to have to mutate in order to survive, which is what we know as cancer. So now I'd like to talk about screening. So mammograms are recommended for women. The age when women are advised to begin having mammograms is going to vary based on each woman's own personal history, including gynecological history, as well as her own family history. Women who have a strong family history of breast cancer will tend to be recommended to undergo mammograms starting sooner, whereas other women who don't have a strong history or a or any other significant breast health issues earlier in life would typically start that later.
Speaker2:
But typically speaking, women are recommended to start getting mammograms around age 40 to 45 depends on which which guidelines you follow. But somewhere in that in that age range and mammograms are certainly controversial as well. They do involve radiation. They do involve compression of the breast, and neither of those is ideal. However, mammograms are the gold standard for diagnosis, or at least at the very least, initial screening for breast cancer. And this brings up an important point. There are two different types of mammograms. There's a screening mammogram, which is performed routinely on women who are asymptomatic, meaning they have not noticed any sort of lump or concerning finding in the breast. And then there are also what are called diagnostic mammograms, which are usually done after a screening mammogram, when a patient has either noticed something herself on an exam or who has had an abnormal finding on a mammogram. So in general, I do recommend mammograms. They're not perfect. We all know stories of women who have had their routine mammograms and had normal mammograms and were subsequently found to have cancer via some other method. But as with any imaging modality, nothing is 100%. It's not always going to be right. But I do think mammograms are generally a good idea to do routinely at the direction of your ob gyn and then ultrasounds or the other main imaging modality we use.
Speaker2:
If there is an abnormality on a mammogram, then the ultrasound is usually the next step. And the advantage to ultrasounds are that they they don't involve any radiation or contrast agents. They're, of course, operator dependent, meaning there is an ultrasound technician who will do the ultrasound and then a radiologist would read it just as they would a mammogram. So those are kind of the two main ways of screening for breast cancer. I have a couple more I'd like to talk about. And the first is routine breast exams. I think a woman needs to be familiar with her own breast, and I typically recommend that self exams occur about once a month. The way I recommend women do self-exams is to basically just feel every area of both breasts. And so, you know, medically we break the breast down into four quadrants. And so it's almost like if you drew a line down the center of the breast vertically and then another line across the breast horizontally. And that leaves us with a four quadrant. So so basically with with two or three fingertips, just lightly press over each area of all four of those quadrants. That's exactly how we would do a breast exam in a patient in the office and just see if you feel anything abnormal, any lumps, anything concerning. Look for any sort of skin changes, texture changes, look for nipple discharge. And even as you feel the breast that that upper outer quadrant actually extends into the armpit, we call that the axilla.
Speaker2:
And so all of these areas are what your gynecologist should be examining when you have a breast exam in his or her office. But doing these monthly on on your own, I found to be very beneficial for women because no one knows your breasts like you do. And so it's one thing to go get an exam every year or two with a doctor, but they're truthfully not going to remember a lot of details about your breasts over that span of time from one visit to the next. And so many women have detected abnormal lumps on their own as a result of self exam. So I highly recommend that. And it's something if you haven't been in the habit of doing, you'll get used to it. It shouldn't be anything you dread or that you find painful, but that's just another way women can be proactive. So I highly recommend that. And then the other screening modality I like is thermography. So thermography is something I do in my office, and it uses a special camera that detects very small changes in heat changes or heat patterns. And so we know that when there are potential cancerous or precancerous areas in the breast, they will tend to have an abnormal heat pattern. We know that cancer is an inflammatory disease and thermography helps detect those very small changes in heat, which can prompt further workup.
Speaker2:
And so thermography again, it's not perfect either. Mammograms aren't perfect, ultrasounds aren't perfect. Neither are thermal Graham's. But I have found thermography to be an excellent tool to combine with the other screening modalities because there have been studies showing that thermography can detect these abnormal precancerous or cancerous changes in some cases years before they're detected on on a mammogram. So I think all of these things in combination, routine screening, mammograms, routine thermography, breast self-exam, and then if there are any abnormalities, ultrasounds as well are just a really good strategy in terms of screening. Now let's assume that a woman has gone through this process and has noted. An abnormality in one, one setting or another, whether it be on self-exam or on imaging. And let's say that the ultrasound was performed and a lump was seen and then that lump was biopsied. And that brings us to the next point. I absolutely recommend biopsies. If there is a concerning finding. We have to know if it's something cancerous or malignant or whether it's something that's benign or or non cancerous. It's very important to know that there's a lot of talk out there in the alternative medicine community about biopsies spreading cancer. Mayo Clinic did a really in-depth study on this a few years ago and found that biopsies don't spread cancer. And as expected, the women who had biopsies and thus obtained a proper diagnosis, you know, lived much longer than the women who likely had cancer and didn't get it diagnosed and therefore didn't get proper treatment.
Speaker2:
So absolutely get the biopsy. It's obviously not the most pleasant thing in the world. It's not something anyone wants to do, but it's extremely helpful in terms of just knowing exactly what we're dealing with. And not surprisingly, you know, many times a lesion will be biopsied and it'll come back benign and it ends up just being a cyst or a lipoma or some sort of benign growth. It's not harmful, but at least we know that. And that can actually change the recommended guidelines in terms of screening as well in order to be more proactive. Now, let's assume that it is cancer. Let's say the biopsy is done and the doctor says those three words that are so scary, you have cancer, what do we do next? And so the main things that we look at on a biopsy that's diagnostic for cancer is what type of cancer is it? There's a few main types of breast cancer. There's one called invasive ductal carcinoma, which means it involves one of the milk ducts. There is invasive mammary carcinoma. There's inflammatory breast cancer, which also involves the skin. And those are really the main types of breast cancer. And then beyond that, we also look on a basic biopsy at the basic characteristics of some things that might be fueling that cancer growth, estrogen receptor or E.R.
Speaker2:
Will be noted as positive or negative. So if it's estrogen receptor positive, that means that estrogen in the body is going to be fueling that cancer growth, which allows it to, of course, spread as well. The next one is progesterone receptor or PR, and that'll be noted as positive or negative as with estrogen. If it's PR positive, that means progesterone in the body is fueling the cancer. If it's PR negative, that means that those hormone receptors were not found on the breast cancer itself in a high level. And then the last is called her to new h.r. And then the number two slash in eu and sometimes we abbreviate her to new as just her too. But HER2 is a growth promoting protein that's located on the outside of all breast cells. But when breast cancer cells have a higher than normal level of this HER2 protein, we call it HER2 positive. And of course, the last main category of breast cancer is what we call triple negative, meaning that the breast cancer doesn't contain any of those three receptors, the the estrogen receptor or progesterone receptor or the HER2. And so triple negative is sort of the fourth main category. And then the other thing on the biopsy report that's important is something called a K, I, 67 and K 67 is a marker of, of that cancer's aggressiveness and growth potential. And so typically a K 67 under about 10% goes from 0 to 100 and less than 10% is considered slower growing.
Speaker2:
And then between ten and 20% is considered intermediate in anything over 20% is considered fast growing. So this can also help in terms of diagnosis and thus treatment as well. So once the initial diagnosis is made and these general characteristics in terms of receptors are better defined, we have to complete our staging. So the next step in staging is typically some sort of imaging. This could either be a breast MRI, which is usually done with and without intravenous contrast. The contrast helps us visualize the different locations a little bit better. And then a CT scan or a CAT scan that's also usually done with intravenous contrast. And then a PET scan, which is sometimes combined with a CT scan. Pet scans also going to use some contrast to to show us areas that may light up ultrasounds can be used to sort of initially look at the different areas of the breast to see if maybe any lymph nodes show up. But but that's really not where we would go for definitive information. We would either do the MRI or the CT scan or the PET scan. So this imaging is done just as with tumors themselves. You know, lymph nodes are going to typically take up contrast if. There if they're cancer. So we look at that and then typically a nearby lymph node to the tumor, which is called a sentinel lymph node, is going to be sampled at some point as well.
Speaker2:
This can either be during the diagnostic process or it can be done when a surgeon is is removing the tumor or the breast to to sample as well. And so this is important to know if the lymph nodes are involved, because when we look at cancer, it's either going to typically spread through the blood or through the lymphatic system. And the lymphatic system is something we really don't talk enough about in in medicine and oncology. But the lymphatic system generally parallels the circulatory system or the bloodstream, and the lymphatic system does a few important things. The first is that it serves as a training ground for our immune system. So immune system cells are made in the bone marrow. These are your white blood cells and your lymphocytes and neutrophils and all those good types of immune cells. And they circulate through the lymphatic system. And the body presents these new recruits, if you will, in basic training, presents them with different substances, and basically teaches these immune system cells which substances are foreign, which is which the immune system then knows to attack versus which substances are native to the body, which the immune system is not supposed to attack. So when this when this balance gets thrown off, that's when we either have autoimmune disease, when the immune system is overactive and attacking things it shouldn't be that are part of the body or an underactive immune system to where it doesn't attack foreign invaders like it's supposed to, like viruses and bacteria and things.
Speaker2:
So lymphatic system is very important for immune system function, but it's also important just for detoxification, for moving all the trash and junk that builds up in the body into areas of the body where it can be eliminated, either the stool or the urine or the sweat glands. Cancer can hijack the lymphatic system and actually use it to spread. And so testing a nearby lymph node is extremely important because if the lymph node is involved, then we need to look at the extent of that. So a common area for breast cancer to spread to is the lymph nodes of the breast and also the lymph nodes in the armpit. So typically on the same side, the armpit on the same side is the breast cancer will often have lymph node involvement with the cancer as well. So staging goes from stage one to stage four. Stage four is the most aggressive and stage one is the least aggressive. So when we talk about a breast cancer and we have just one primary tumor or lesion in the breast, if that's all that exists and the lymph nodes are not involved, then that cancer will be stage at either stage one or stage two. And the threshold between one and two is basically just based on size.
Speaker2:
So if it's a smaller tumor, then it's a stage one. If it's a larger tumor, it's stage two. And then the lymph node involvement, if there if the if a lymph node is shown to have cancer in it, then that automatically gets us to stage three breast cancer and then more distance spread to other locations, such as the bone or the lung or the liver or different places like that gets us to stage four. So as you can imagine, stage one has the best prognosis, stage four has the worst prognosis. So it's important to get a good screening and then also a good diagnosis with proper staging so that we actually know what we're dealing with because that will dictate treatment. Hi, this is Dr. Jonathan Stegall, medical doctor and specialist in integrative oncology. And I want to tell you about my new bestselling book, Cancer Secrets. This book is packed with valuable information you need to know about whether you're searching for information for yourself or for a loved one. In my book, you'll learn what cancer is and what it is not, as well as which treatments you should be focusing on from both modern medicine as well as alternative medicine. You'll also learn the ins and outs of nutrition and supplementation, as well as important information about having the proper mindset. I'm in the trenches every day with patients and I've shared my secrets in this book with you.
Speaker2:
Please go to Cancer Secrets and buy your copy now. So getting back to our patient, let's say she's a stage one breast cancer and let's say let's say she's estrogen receptor positive and progesterone receptor positive. The first thing she needs to do is have surgery. So so that stage one patient is an excellent surgical candidate, ideally a lumpectomy, which means just taking out the tumor itself. Mastectomy is another option depending on the location of the tumor and then certainly how aggressive the patient and her surgeon wants to be. But that's a real personal decision. You know, I've recommended lumpectomies and I've recommended mastectomies. I don't feel strongly one way or the other. I think a lot of that comes down to a woman's personal decision in that situation. You know, obviously, a lumpectomy is is going to spare the breast for the most part. A mastectomy means taking off the whole breast. Women who are prone to worry about recurrence in that breast typically are going to be better served doing a mastectomy, although that's going to potentially still leave some cells behind. You can't remove them all. And then that may also involve reconstruction as well. And so that's a whole nother discussion for another episode. But but basically that's kind of the decision I would would take the patient through is okay, let's first do surgery and then for some patients with stage one, they won't even need chemotherapy.
Speaker2:
They may not need it depending on some characteristics of their their tumor on diagnosis. And this brings up an important test I want to talk about called onco type DCS. The ONCO type DCS test is a is a commonly used test in conventional oncology, and it's for early stage women who have hormone positive cancer. So it's typically going to be PR positive stage one, sometimes stage two, but early stage. And it actually looks at some genetic characteristics to better evaluate whether that woman would benefit from chemotherapy or not. So obviously, we don't want to use chemotherapy if we don't have to. But but it's kind of a nice starting point to to give us an opportunity to make an informed decision. And then that same woman after surgery is going to need to address her hormonal status. And so this is when we talk about menstrual cycles and menopause. A woman who's premenopausal, still having regular menstrual cycles will need typically to go on a medication that not only blocks the hormone themselves, which would be something like estrogen blockers, but also inhibits the release of stimulatory hormones like FSH and LH that are made in the pituitary gland that actually signal the production of the hormones as well. A woman who's having a menstrual cycle has much higher hormone levels than a woman who is post-menopausal. And so we have to sort of block the hormones that way. And again, this is not ideal having to block hormones.
Speaker2:
You know, women, there's a lot of good reasons to have a menstrual cycle, not only fertility, but also just the body's healthy, functioning. A woman, you know, who's in her thirties or forties typically is going to need those hormones if possible. So by blocking those hormones, either through blocking the production or blocking their activity, it will put that woman into basically a chemical menopause and in and result in side effects that go along with that. And that can be things like hot flashes, night sweats, you know, irritability, things like that, mood changes. And so that's, again, a serious discussion that the patient needs to have with with her doctor. But I typically do recommend addressing these hormones in this fashion because they're preferred fuel for the cancer cells. So if we don't reduce those hormone levels significantly, that cancer is going to continue to progress even after surgery. There's still certainly some cells involved that are cancerous. And we don't want to give those cells the fuel that they need to grow larger and cause problems down the road. And then, of course, in the case of postmenopausal women who are no longer having a period, it's a little bit simpler. It would simply mean just blocking the low level of estrogen that exists in the body. And that's usually done with either the drug Tamoxifen or the drug a remedy. And so that's a little bit easier conversation, but we still want to address the hormones in that case as well.
Speaker2:
And then in terms of supplements, I really like the supplement called Dimm Dimm that stands for Die and a Little Methane. And it comes from cruciferous vegetables like broccoli and cauliflower and Brussels sprouts and things like that. But obviously you can't eat enough of those vegetables to get a therapeutic level of dimm. So we use it as a supplement. But what it does is it actually helps estrogen in the body be broken down in a in a safe way because we know that estrogen can go down more of a harmful pathway, which is more cancer promoting versus being taken down a more healthy pathway, which is less cancer promoting and more beneficial to the body. So sort of that one two punch between blocking the production of hormones and then actually also pairing that with something like Dimm to help better break down the hormones that are still there. I found to be an excellent strategy. And then finally, let's. Take a woman who is either triple positive, which would be er positive, PR positive and HER2 positive or a woman who doesn't have the hormone involvement and is just HER2 positive. The standard of care for those patients is typically the drug Herceptin, which is a form of what we call immunotherapy, which harnesses the body's immune system to try to attack the cancer better. And then now with recent trials that have come out, this is typically paired with the drug called Perjeta, which does a similar thing targeting that HER2 receptor.
Speaker2:
And again, this is these are newer treatments. I don't use Herceptin or Perjeta in my office for a few reasons. I don't think they're wrong for every patient. Never discourage a patient from pursuing those treatments. But I am just not to the point of using them in my office. I do have some concerns when we start to mess around with the immune system too much. The problem can be with these drugs. We can overstimulate the immune system, we can create autoimmune disease sometimes with with lifetime side effects in terms of reduced or no functioning of certain organs. I've seen these drugs affect the skin, the adrenal glands, the colon with with lasting symptomatic side effects. And so I do try to be careful in recommending them. I think it needs to to be after a thorough discussion with the patient. And so my patients who are on those drugs typically will go to their more conventional oncologists for that. I don't do that in my office. And then the last piece to that puzzle, in addition to the Herceptin and Perjeta is is heart involvement. So so these drugs are known to cause cardiotoxicity and so to if a woman is going to be receiving those treatments, she would get a baseline echocardiogram to look at her heart and make sure it's functioning properly.
Speaker2:
And then a repeat echocardiogram would need to be done at some point, pretty soon down the road, usually after two or three months on therapy to reevaluate. So I have had patients who have had to stop Herceptin and or Perjeta because they had some heart involvement. Perjeta typically is only done for several months because it can be extremely cardio toxic. And then Herceptin, if everything's going well, will usually be done for up to a year. So despite all of my concerns about these drugs, they are the standard of care for a reason. We do have good research on them and many women will receive them with great results and know no real significant side effects. And then the final category is triple negative. So that means it's er negative, PR negative and the HER2 new negative and this typically is the most aggressive form of breast cancer because it doesn't provide as many treatment targets for us. So it's the nice thing about the the hormone receptors and the HER2 is that we can target those with various treatments. Triple negative doesn't have really any obvious targets. So we're basically left with surgery and chemotherapy. And so we have to really, really make sure we stay on top of triple negative. I mean, that goes for every breast cancer, but especially triple negative. If typically, if you can make it to the five year survival mark, then then you're doing really well with triple negative.
Speaker2:
And your your prognosis for an otherwise normal life is much, much better if you make it to that five year mark after after you undergo treatment. So we talked about different types of breast cancer. We've talked about staging. Let's talk a little bit about chemotherapy. There are various regimens for chemotherapy, for breast cancer. If you go to a regular, conventionally minded oncologist, they're going to pretty much consult the flowchart of recommended chemo's for that given type of breast cancer. The main one that that I kind of consider the authority in terms of guidelines is the NCCN, the National Comprehensive Cancer Network. And so I look at those guidelines all the time. I use them to inform me because they're they're evidence based and they're very important. But then I also like to do advanced testing as well. And so my favorite test to do, and I've mentioned this in a previous episode is called the Cross Molecular Intelligence Test. And so Karas is a lab out in Arizona. And typically we like to do this test soon after the biopsy or the surgery has taken place. So so Chris will obtain the slides that are made from that tissue, from biopsy or surgery, and they will obtain those slides from the pathology lab where your sample is is held basically. And they will obtain those and do very advanced genetic testing on that tissue.
Speaker2:
And they will provide a report that shows the different mutations that they identify. And this is this is a much more in-depth genetic test than just a biopsy. So the Kara's test will will identify specific mutations, which will then guide treatment decisions on chemotherapy. So I love to do this test, ideally right out of the gate before a woman has even started any sort of treatment yet other than surgery and and really see what that genetic pattern is. I mean, this to me is the essence of personalized medicine, where obtaining specific information on your cancer and we're making decisions on which chemotherapies to use that are targeting the mutations that that test has found in your cancer. I just think this is wonderful. I mean, why continue to guess and give everyone the same treatment just because it's the first line treatment or the second line treatment? Why don't we test it? Why don't we see on a great test that's in the US it's validated. Insurance actually typically will cover it. And why not do this testing to better guide us in our therapy? So I love to do the Kara's test. I let that guide me on my chemotherapy decisions with a patient. And of course we do chemotherapy different in my office. We do fractionated metronomic chemotherapy, meaning we give smaller doses more often and we find this to be much better tolerated. It allows us to hit the cancer more often and actually get it a nice immune stimulating benefit in a in a good way from that as well.
Speaker2:
And so that's how we do it in our office. And then of course, the hormonal treatment, if that applies to the patient as well. And finally, diet, know diet in terms of treating breast cancer is going to be a little different depending on the patient and her diagnosis. And generally speaking, that's going to be a plant based, unprocessed or very minimally processed diet, focusing on organic vegetables, organic fruits, you know, plenty of of those cruciferous vegetables, like we mentioned, broccoli, cauliflower, Brussels sprouts, making sure to include a lot of the nice anti cancer fruits and vegetables, things like the berries, carrots, things like that. And then I do think especially women who have hormone positive cancer need to be especially careful about animal protein, especially animal protein sources like like chicken, beef, fish and then dairy as well. Just making sure to go organic as much as possible to avoid all of the animals that have been given growth hormones, antibiotics and things like that. Because I do believe that that can be transmitted through the meat or the the dairy in some fashion and then be therefore ingested into that patient's body. So I think we need to be especially careful about that. There's also a lot of discussion about soy. I'm generally not a big fan of soy simply because it tends to be genetically modified.
Speaker2:
If it's a good source of soy, I'm open minded to it. There are a lot of people think that soy is bad if it's breast cancer. Some people think it's good if it's breast cancer. There have been some studies showing that soy can help prevent breast cancer, but there haven't really been any clear guidelines on whether soy in patients already with breast cancer is beneficial or harmful. So I don't think you need to make soy a staple of your diet regardless. But if you have a little bit here and there, I don't think it's going to be a big deal. So I hope this has been a helpful episode, just kind of walking through not only breast cancer and what it is, but also the best screening guidelines, how it should be diagnosed, and then conventional treatment, plus alternative treatment, which gives us our integrative approach. We're combining both of those in the best way for each patient, and that's the essence of personalized medicine. And I believe that's the key to having better cancer treatment outcomes. I see them in my office every day and I believe in this so much. And that's why I do this podcast, because I want to get the word out there about this kind of cancer treatment. So if you're dealing with breast cancer, I hope you found this helpful. I know there are some things here you've probably heard before, especially if you're seeing a conventional oncologist, but there's probably some things you had not heard about as well.
Speaker2:
And so I encourage you to speak with your doctor about this. Hopefully he or she will be receptive because these are things that have some good research behind them and unfortunately just haven't. Become part of the routine standard of care yet, but I'm determined that they will. So again, I hope this has been helpful. Thank you for being a part of this show. Honored to get to spend this time with you. And we just continue to be extremely just humbled by the emails we get and just seeing where where our message is is going. I mean, we hear from patients all over the world who are listening to this podcast and who are finding it so beneficial to them. So I'm honored to be a part of your journey, whether it's for you or as the patient or whether you're listening for a loved one. I'm honored to be a part of it. Thank you for listening and I look forward to next time. And as I mentioned in a previous episode, I'm very excited about what lies ahead. In season two. We're going to have some excellent interviews with some some wonderful guests. I think you're going to be very entertained by and just be very blessed by to hear their stories. So look forward to seeing you next time. Bye bye.
Speaker1:
Thank you for listening to the Cancer Secrets podcast. If you were encouraged by this show, please share it with a loved one or friend. Help support the show by leaving us a rating and review on iTunes. The more reviews, the more friends like you can find the show. Finally, to learn more, visit us online at DRS de Goal.com. The Cancer Secrets Podcast. Changing the Cancer Paradigm.
Sonix is the world’s most advanced automated transcription, translation, and subtitling platform. Fast, accurate, and affordable.
Automatically convert your mp3 files to text (txt file), Microsoft Word (docx file), and SubRip Subtitle (srt file) in minutes.
Sonix has many features that you’d love including automated translation, powerful integrations and APIs, upload many different filetypes, secure transcription and file storage, and easily transcribe your Zoom meetings. Try Sonix for free today.